Universal Electronics Inc. (UEIC) Q4 2025 Earnings Conference Call August 7, 2025 4:30 PM ET
Company Participants
Paul Josephs – President, CEO & Director
Ryan D. Lake – EVP & CFO
Conference Call Participants
Matthew Gregory Hewitt – Craig-Hallum Capital Group LLC, Research Division
Maxwell Andrew Smock – William Blair & Company L.L.C., Research Division
Michael John Petusky – Barrington Research Associates, Inc., Research Division
Stephanie C. Diaz – Vida Strategic Partners, Inc.
Operator
Good afternoon, and thank you for joining Lifecore’s Fiscal 2025 Fourth Quarter and Full Year Earnings Call. [Operator Instructions] Now I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for Lifecore. Please go ahead.
Stephanie C. Diaz
Good afternoon, and thank you for joining us today to discuss Lifecore Biomedical’s Fourth Quarter and Full Year Fiscal 2025 Earnings Results. Hosting the call today from Lifecore are Paul Josephs, President and Chief Executive Officer; and Ryan Lake, Chief Financial Officer.
Before we begin today, we’d like to remind everyone that certain statements made in the course of this conference call contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management’s judgment and analysis only as of today, August 7, 2025, and the company’s actual results could differ materially from those projected in such forward-looking statements. For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included in our fourth quarter and fiscal year 2025 earnings press release, which was furnished to the SEC today on Form 8-K and is available on our corporate website at lifecore.com as well as our other filings with the Securities and Exchange Commission, including, but not limited to, the company’s Form 10-K for the fiscal year ended May 25, 2025, which was filed this afternoon and is
#Lifecore #Biomedical #LFCR #Earnings #Call #Transcript